Gyan Barik: First-In-Human Trial for Axana Stroke Detection Is Complete
Gyan Barik, Executive Director at Wellumio, shared Wellumio‘s post on LinkedIn, adding:
”Thrilled to share: Wellumio’s FIRST-IN-HUMAN trial for Axana stroke detection tech is COMPLETE at Royal Melbourne Hospital!
A game-changer for faster stroke decisions, huge thanks to participants, families, RMH teams (shoutout Dr James Barker, Amy MacDonald, Profs Geoffrey Donnan and Stephen Davis), and all partners.
Invaluable insights gained.
Phase 2, here we come!”
Quoting Wellumio‘s post:
”We’re very excited to announce the completion of our first-in-human clinical trial at The Royal Melbourne Hospital.
This is a major milestone and a significant step forward for Axana as we work to accelerate stroke detection and decision-making in time-critical settings.
First and foremost, we thank the study participants and their families.
This study would not have been possible without their generosity and willingness to support the advancement of medical technology.
We are also incredibly grateful to the clinicians, investigators, and research teams at RMH, along with all of our collaborators and partners who helped make this possible.
In particular, we’d like to acknowledge Dr James Barker and Amy MacDonald for coordinating the study day to day, and Professors Geoffrey Donnan and Stephen Davis from the Australian Stroke Alliance as the site Principal Investigators.
This trial has generated invaluable insights, and we’re looking forward to returning to the clinic for our Phase 2 trial.”
Stay updated with Hemostasis Today.
-
Apr 18, 2026, 01:1679th World Health Assembly: ‘Advancing Health Equity for Bleeding Disorders’ – WFH
-
Apr 18, 2026, 00:44Join leading experts for an evening symposium at the ASPHO Conference – ISTH
-
Apr 17, 2026, 17:41José Antonio García Erce: Hematology in 48 H Day 1 What You Need to Know for Clinical Practice
-
Apr 17, 2026, 17:23Alfonso J. Tafur: Endovascular Therapy Improves Post-Thrombotic Syndrome Outcomes at 6 Months
-
Apr 17, 2026, 17:09Hayley Taylor: Whatever Your Blood Type if You Can Donate Please Do It Because You Could Help Save a Life
-
Apr 17, 2026, 16:51Ney Carter Borges: Additive Cardiovascular Risk Reduction Through Dual Targeting of Lipoprotein(a) and Interleukin-6 Signalling
-
Apr 17, 2026, 16:08David McIntosh: African Healthcare and European Partnerships in Plasma Medicine
-
Apr 17, 2026, 16:05Ana Pedrero Gil: How Are Intraoperative PRBC Transfusions Associated with Postoperative Delirium in Adults
-
Apr 17, 2026, 16:00William Aird: The Satisfaction of Recognising the Symptom Patterns in Iron Deficiency